Your browser doesn't support javascript.
loading
T Cell-intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia.
Lam, Vi; Roleder, Carly; Liu, Tingting; Bruss, Nur; Best, Scott; Wang, Xiaoguang; Phillips, Tycel; Shouse, Geoffrey; Berger, Allison J; Alinari, Lapo; Wang, Lili; Siddiqi, Tanya; Pennock, Nathan D; Danilov, Alexey V.
Afiliação
  • Lam V; City of Hope National Medical Center, Duarte, California.
  • Roleder C; City of Hope National Medical Center, Duarte, California.
  • Liu T; City of Hope National Medical Center, Duarte, California.
  • Bruss N; City of Hope National Medical Center, Duarte, California.
  • Best S; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Wang X; City of Hope National Medical Center, Duarte, California.
  • Phillips T; City of Hope National Medical Center, Duarte, California.
  • Shouse G; City of Hope National Medical Center, Duarte, California.
  • Berger AJ; Takeda Development Center Americas Inc., Lexington, Massachusetts.
  • Alinari L; The Ohio State University, Columbus, Ohio.
  • Wang L; City of Hope National Medical Center, Duarte, California.
  • Siddiqi T; City of Hope National Medical Center, Duarte, California.
  • Pennock ND; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Danilov AV; City of Hope National Medical Center, Duarte, California.
Mol Cancer Ther ; 22(9): 1040-1051, 2023 09 05.
Article em En | MEDLINE | ID: mdl-37420267

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Ubiquitina Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Ubiquitina Idioma: En Ano de publicação: 2023 Tipo de documento: Article